“…Moreover, large, long‐term studies have found that although intermediate‐ and high‐risk patients always benefit from radical surgery versus watchful waiting, the same is not true for men harboring low‐risk PCa: immediate radical treatment is rarely beneficial for these men, and it exposes them to the morbidity of radical prostatectomy without a gain in survival. As such, indications for radical prostatectomy, open or minimally invasive, are shifting toward the treatment of higher grade, higher stage, and higher risk disease …”